GUARDANT HEALTH INC(NASDAQ:GH) stock News

GH Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Guardant Health, Inc.

Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025

9 days ago - By: Benzinga

What Does the Market Think About Guardant Health Inc?

13 days ago - By: Zacks Investment Research - Mentions: DGX QGEN EXAS

DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute

14 days ago - By: Guardant Health, Inc.

FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer

19 days ago - By: Guardant Health, Inc. - Mentions: DGX

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States

a month ago - By: Guardant Health, Inc.

Alex M. Azar II Joins Guardant Health Board of Directors

a month ago - By: Guardant Health, Inc.

Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership

a month ago - By: Guardant Health, Inc.

Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States

a month ago - By: Zacks Investment Research - Mentions: EXAS TEM

What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?

a month ago - By: Investor's Business Daily - Mentions: EXAS

Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run

a month ago - By: Guardant Health, Inc.

Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test

2 months ago - By: Guardant Health, Inc.

Guardant Health to Host Investor Day on September 24, 2025

2 months ago - By: Guardant Health, Inc.

Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

2 months ago - By: Guardant Health, Inc.

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Zacks Investment Research - Mentions: TMO ILMN EXAS

TMO Receives FDA Approval for Oncomine Dx Target Test

2 months ago - By: Zacks Investment Research - Mentions: EXAS TEM

TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?

2 months ago - By: Benzinga - Mentions: IBP PAYC APP LOPE ...

GUARDANT HEALTH INC (GH) Stock News

GH Latest News, Press Relases and Analysis

Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025

What Does the Market Think About Guardant Health Inc?

DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute

FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer

Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States

Alex M. Azar II Joins Guardant Health Board of Directors

Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership

Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States

What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?

Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run

Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test

Guardant Health to Host Investor Day on September 24, 2025

Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TMO Receives FDA Approval for Oncomine Dx Target Test

TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?

Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday